Cardiomyocyte Protection by GATA-4 Gene Engineered Mesenchymal Stem Cells Is Partially Mediated by Translocation of miR-221 in Microvesicles

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Yu, Bin ^a   Gong, Min ^a   Wang, Yigang ^a   Millard, Ronald W ^a   Pasha, Zeeshan ^a   Yang, Yueting ^a   Ashraf, Muhammad ^a   Xu, Meifeng ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CD63 ANTIGEN; CD9 ANTIGEN; HEAT SHOCK PROTEIN 70; LACTATE DEHYDROGENASE; MICRORNA 221; MICRORNA 222; PUMA PROTEIN; TRANSCRIPTION FACTOR GATA 4;

ANIMAL CELL; ARTICLE; CELL ENGINEERING; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACELLULAR SPACE; GATA 4 GENE; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENE LOCATION; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE; INTERNALIZATION; MALE; MESENCHYMAL STEM CELL; NEWBORN; NONHUMAN; RAT; UPREGULATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL HYPOXIA; COCULTURE TECHNIQUES; GATA4 TRANSCRIPTION FACTOR; HEART VENTRICLES; MALE; MESENCHYMAL STROMAL CELLS; MICRORNAS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84883426378     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073304     Document Type: Article

References (38)

1. Tongers J, Losordo DW, Landmesser U, (2011) Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 32: 1197-1206.
2. Leri A, Hosoda T, Rota M, Kajstura J, Anversa P, (2007) Myocardial Regeneration by Exogenous and Endogenous Progenitor Cells. Drug Discov Today Dis Mech 4: 197-203.
3. Poynter JA, Herrmann JL, Manukyan MC, Wang Y, Abarbanell AM, et al. (2011) Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism. J Am Coll Surg 213: 253-260.
4. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
5. Uemura R, Xu M, Ahmad N, Ashraf M, (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation Research 98: 1414-1421.
6. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, et al. (2009) Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 106: 14022-14027.
7. Angoulvant D, Ivanes F, Ferrera R, Matthews PG, Nataf S, et al. (2011) Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant 30: 95-102.
8. Boonbaichaiyapruck S, Pienvichit P, Limpijarnkij T, Rerkpattanapipat P, Pongpatananurak A, et al. (2010) Transcoronary infusion of bone marrow derived multipotent stem cells to preserve left ventricular geometry and function after myocardial infarction. Clin Cardiol 33: E10-15.
9. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, et al. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-148.
10. Assmus B, Rolf A, Erbs S, Elsasser A, Haberbosch W, et al. (2010) Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 3: 89-96.
11. Yousef M, Schannwell CM, Kostering M, Zeus T, Brehm M, et al. (2009) The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 53: 2262-2269.
12. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, et al. (2009) Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 30: 2978-2984.
13. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, et al. (2005) Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96: 127-137.
14. Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, et al. (2007) Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A 104: 17783-17788.
15. Boomsma RA, Geenen DL, (2012) Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PLoS One 7: e35685.
16. Zeng L, Hu Q, Wang X, Mansoor A, Lee J, et al. (2007) Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115: 1866-1875.
17. Burchfield JS, Dimmeler S, (2008) Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair 1: 4.
18. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, et al. (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. Faseb J 20: 661-669.
19. Shabbir A, Zisa D, Suzuki G, Lee T, (2009) Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol 296: H1888-1897.
20. Nguyen BK, Maltais S, Perrault LP, Tanguay JF, Tardif JC, et al. (2010) Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. J Cardiovasc Transl Res 3: 547-558.
21. Camussi G, Deregibus MC, Cantaluppi V, (2013) Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans 41: 283-287.
22. Lai RC, Chen TS, Lim SK, (2011) Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 6: 481-492.
23. Biancone L, Bruno S, Deregibus MC, Tetta C, Camussi G, (2012) Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27: 3037-3042.
24. Zhang CZ, Zhang JX, Zhang AL, Shi ZD, Han L, et al. (2010) MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9: 229.
25. Sharma AD, Narain N, Handel EM, Iken M, Singhal N, et al. (2011) MicroRNA-221 regulates FAS-induced fulminant liver failure. Hepatology 53: 1651-1661.
26. Jabbour AM, Heraud JE, Daunt CP, Kaufmann T, Sandow J, et al. (2009) Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim. Cell Death Differ 16: 555-563.
27. Vaux DL, Cory S, Adams JM, (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
28. Villunger A, Scott C, Bouillet P, Strasser A, (2003) Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival. Blood 101: 2393-2400.
29. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, et al. (2000) The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 6: 1389-1399.
30. Li H, Zuo S, He Z, Yang Y, Pasha Z, et al. (2010) Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival. Am J Physiol Heart Circ Physiol 299: H1772-1781.
31. Zhang X, Wang X, Zhu H, Zhu C, Wang Y, et al. (2010) Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol 49: 841-850.
32. Xu M, Wani M, Dai YS, Wang J, Yan M, et al. (2004) Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation 110: 2658-2665.
33. Sadat S, Gehmert S, Song YH, Yen Y, Bai X, et al. (2007) The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun 363: 674-679.
34. Gnecchi M, Zhang Z, Ni A, Dzau VJ, (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219.
35. Follis AV, Chipuk JE, Fisher JC, Yun MK, Grace CR, et al. (2013) PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis. Nat Chem Biol.
36. Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, et al. (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 4: e4722.
37. Chen L, Wang Y, Pan Y, Zhang L, Shen C, et al. (2013) Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem Biophys Res Commun.
38. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.